Samir B Pancholy1, Ghanshyam Palamaner Subash Shantha2, Enrico Romagnoli3, Sasko Kedev4, Ivo Bernat5, Sunil V Rao6, Sanjit Jolly7, Olivier F Bertrand8, Tejas M Patel9. 1. The Wright Center for Graduate Medical Education, The Commonwealth Medical College, Scranton, PA. Electronic address: pancholys@gmail.com. 2. The Wright Center for Graduate Medical Education, Scranton, PA. 3. Interventional Cardiology Unit, Ospedale Belcolle, Viterbo, Italy. 4. University Clinic of Cardiology, Skopje, Macedonia. 5. University Hospital and Faculty of Medicine, Pilsen, Czech Republic. 6. The Duke Clinical Research Institute, Durham, NC. 7. Population Health Research Institute, Hamilton, Ontario, Canada. 8. Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. 9. Apex Heart Institute, Ahmedabad, India.
Abstract
BACKGROUND: The benefit of transradial access (TRA) in patients with cardiogenic shock (CS) is uncertain. We sought to determine the benefits of TRA in patients with CS undergoing coronary angiography/intervention. METHODS: MEDLINE, Embase, Cochrane Central, and electronic databases were searched for studies that assessed the following: (1) patients with CS who underwent percutaneous coronary intervention (PCI) and (2) the association between choice of arterial access, 30-day all-cause mortality, and 30-day major adverse cardiac and cerebral events (MACCEs) using random-effects model. RESULTS: From 3,652 retrieved citations, 8 studies involving 8,131 patients with CS undergoing PCI (via TRA: 2,321 patients, via TFA: 5,810 patients) were included. Transradial access was associated with significantly reduced risk for all-cause mortality (unadjusted: risk ratio [RR] 0.60, 95% CI 0.52-0.71, P < .001, I(2) = 29%, 8 included studies; adjusted: RR 0.55, 95% CI 0.46-0.65, P < .001, I(2) = 0%, 6 included studies) and MACCE (unadjusted: RR 0.68, 95% CI 0.63-0.73, P < .001, I(2) = 0%, 6 included studies; adjusted: RR 0.63, 95% CI 0.52-0.75, P < .001, I(2) = 0%, 4 included studies) at 30 days when compared with TFA. CONCLUSIONS: Transradial access is associated with reduced mortality and MACCE at 30 days in patients with CS undergoing PCI. Considering the possible influence of selection bias on the effect estimate in our analysis, randomized controlled trials are needed to better assess this association.
BACKGROUND: The benefit of transradial access (TRA) in patients with cardiogenic shock (CS) is uncertain. We sought to determine the benefits of TRA in patients with CS undergoing coronary angiography/intervention. METHODS: MEDLINE, Embase, Cochrane Central, and electronic databases were searched for studies that assessed the following: (1) patients with CS who underwent percutaneous coronary intervention (PCI) and (2) the association between choice of arterial access, 30-day all-cause mortality, and 30-day major adverse cardiac and cerebral events (MACCEs) using random-effects model. RESULTS: From 3,652 retrieved citations, 8 studies involving 8,131 patients with CS undergoing PCI (via TRA: 2,321 patients, via TFA: 5,810 patients) were included. Transradial access was associated with significantly reduced risk for all-cause mortality (unadjusted: risk ratio [RR] 0.60, 95% CI 0.52-0.71, P < .001, I(2) = 29%, 8 included studies; adjusted: RR 0.55, 95% CI 0.46-0.65, P < .001, I(2) = 0%, 6 included studies) and MACCE (unadjusted: RR 0.68, 95% CI 0.63-0.73, P < .001, I(2) = 0%, 6 included studies; adjusted: RR 0.63, 95% CI 0.52-0.75, P < .001, I(2) = 0%, 4 included studies) at 30 days when compared with TFA. CONCLUSIONS: Transradial access is associated with reduced mortality and MACCE at 30 days in patients with CS undergoing PCI. Considering the possible influence of selection bias on the effect estimate in our analysis, randomized controlled trials are needed to better assess this association.
Authors: Shariq Shamim; Fengming Tang; David Safley; Philip Jones; John A Spertus; Dmitri Baklanov Journal: Am J Cardiol Date: 2017-03-30 Impact factor: 2.778
Authors: Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Peter S Pang; Razvan I Radu; Elena-Laura Antohi; Josep Masip; Javed Butler; Vlad Anton Iliescu Journal: Am J Ther Date: 2019 Mar/Apr Impact factor: 2.688
Authors: Muhammad Junaid Ahsan; Soban Ahmad; Azka Latif; Noman Lateef; Mohammad Zoraiz Ahsan; Waiel Abusnina; Sandeep Nathan; S Elissa Altin; Dhaval S Kolte; John C Messenger; Mark Tannenbaum; Andrew M Goldsweig Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-09-05
Authors: Ahmed A Kolkailah; Rabah S Alreshq; Ahmed M Muhammed; Mohamed E Zahran; Marwah Anas El-Wegoud; Ashraf F Nabhan Journal: Cochrane Database Syst Rev Date: 2018-04-18
Authors: Behnam N Tehrani; Abdulla A Damluji; Matthew W Sherwood; Carolyn Rosner; Alexander G Truesdell; Kelly C Epps; Edward Howard; Scott D Barnett; Anika Raja; Christopher R deFilippi; Charles E Murphy; Christopher M O'Connor; Wayne B Batchelor Journal: Catheter Cardiovasc Interv Date: 2020-08-03 Impact factor: 2.585